U.S. markets open in 8 hours 5 minutes

Cue Health Inc. (HLTH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.3000+0.0900 (+2.80%)
At close: 04:00PM EDT
3.1000 -0.20 (-6.06%)
After hours: 07:30PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close3.2100
Bid0.0000 x 1200
Ask0.0000 x 1400
Day's Range3.0900 - 3.3100
52 Week Range2.7500 - 16.2000
Avg. Volume504,446
Market Cap485.678M
Beta (5Y Monthly)N/A
PE Ratio (TTM)15.71
EPS (TTM)0.2100
Earnings DateAug 10, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
96% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HLTH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cue Health Inc.
    Analyst Report: Qiagen N.V.Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%).
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
  • PR Newswire

    Cue Health Appoints Suzanne Stone as New Chief Commercial Officer

    Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed Suzanne Stone as its new Chief Commercial Officer. Stone brings over 25 years of experience building high- performing sales and marketing organizations in rapidly growing biotech and medical device companies, most recently at DexCom, Inc.

  • Simply Wall St.

    With 40% ownership, Cue Health Inc. (NASDAQ:HLTH) has piqued the interest of institutional investors

    To get a sense of who is truly in control of Cue Health Inc. ( NASDAQ:HLTH ), it is important to understand the...

  • PR Newswire

    Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer

    Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David Tsay, MD, PhD, as its Chief Medical Officer. Dr. Tsay comes to Cue with more than 20 years of experience in clinical medicine, research, and health technology. Most recently, Dr. Tsay served at Apple, where he led an Apple Health clinical team in developing new Health products, including FDA-cleared products in cardiovascular health.